Profile of differentially expressed genes after transfer of chromosome 17 into the breast cancer cell line CAL51

Genes Chromosomes and Cancer

Volumn 44, Issue 3, 2005, Pages 233-246

  Klebig, Christiane ^a   Seitz, Susanne ^b   Korsching, Eberhard ^c   Kristiansen, Glen ^a   Gustavus, Dirk ^b   Scherneck, Siegfried ^b   Petersen, Iver ^a,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; PROTEIN;

ARTICLE; BREAST CANCER; CELL CYCLE; CELL PROLIFERATION; CHROMOSOME 17; CONTROLLED STUDY; DNA MICROARRAY; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENE TRANSFER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUBTRACTIVE HYBRIDIZATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; UNINDEXED SEQUENCE;

BREAST; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 17; GENE EXPRESSION PROFILING; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 25844513590     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20240     Document Type: Article

References (32)

1. An Q, Pacyna-Gengelbach M, Schlüns K, Deutschmann N, Guo S, Gao Y, Zhang J, Cheng S, Petersen I. 2003. Identification of differentially expressed genes in immortalized human bronchial epithelial cell line as a model for in vitro study of lung carcinogenesis. Int J Cancer 103:194-204.
2. Chen Y, Hühn D, Knösel T, Pacyna-Gengelbach M, Deutschmann N, Petersen I. 2004. Downregulation of connexin 26 in human lung cancer is related to promoter methylation. Int J Cancer 113:14-21.
3. Cho SJ, La M, Ahn JK, Meadows GG, Joe CO. 2001. Tob-mediated cross-talk between MARCKS phosphorylation and ErbB-2 activation. Biochem Biophys Res Commun 283:273-277.
4. Fukino K, Iida A, Teramoto A, Sakamoto G, Kasumi F, Nakamura Y, Emi M. 1999. Frequent allelic loss at the TOC locus on 17q25.1 in primary breast cancers. Genes Chromosomes Cancer 24:345-350.
5. Hirst J, Bright NA, Rons B, Robinson MS. 1999. Characterization of a fourth adaptor-related protein complex. Mol Biol Cell 10:2787-2802.
6. Hoff C, Mollenhauer J, Waldau B, Hamann U, Poustka A. 2001. Allelic imbalance and fine mapping of the 17p13.3 subregion in sporadic breast carcinomas. Cancer Genet Cytogenet 129:145-149.
7. Iwanaga K, Sueoka N, Sato A, Sakuragi T, Sakao Y, Tominaga M, Suzuki T, Yoshida Y, K-Tsuzuku J, Yamamoto T, Hayashi S, Nagasaki K, Sueoka E. 2003. Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer. Cancer Lett 202:71-79.
8. Janke J, Schlüter K, Jandrig B, Theile M, Kolble K, Arnold W, Grinstein E, Schwartz A, Estévez-Schwarz L, Schlag PM, Jockusch BM, Scherneck S. 2000. Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1. J Exp Med 191:1675-1685.
9. Khacri P, Draghici S, Ostermeier GC, Krawecz SA. 2002. Profiling gene expression using onto-express. Genomics 79:266-270.
10. Kittler JT, Rostaing P, Schiavo G, Fritschy J, Olsen R, Triller A, Moss SJ. 2001. The subcellular distribution of GABARAP and its ability to interact with NSF suggest a role for this protein in the intracellular transport of GABA(A) receptors. Mol Cell Neurosci 18:13-25.
11. Klebig C, Seitz S, Arnold W, Deutschmann N, Pacyna-Gengelbach M. Scherneck S. Petersen I. 2005. Characterization of GABARAP, a novel tumor suppressor, showing reduced expression in breast cancer. Cancer Res 65:394-400.
12. Konishi H, Takahashi T, Kozaki K, Yatabe Y, Mitsudomi T, Fujii Y, Sugiura T, Matsuda H, Takahashi T, Takahashi T. 1998. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers. Oncogene 17:2095-2100.
13. Lee J, Welch DR. 1997. Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display. Int J Cancer 71:1035-1044.
14. Maekawa M, Nishida E, Tanoue T. 2002. Identification of the Antiproliferative protein Tob as a MAPK substrate. J Biol Chem 277:37783-37787.
15. Matsuda S, Kawamura-Tsuzuku J, Ohsugi M, Yoshida M, Emi M, Nakamura Y, Onda M, Yoshida Y, Nishiyama A, Yamamoto T. 1996. Tob, a novel protein that interacts with p185erbB2, is associated with anti-proliferative activity. Oncogene 12:705-713.
16. Moog-Lutz C, Tomasetto C, Regnier CH, Wendung C, Lutz Y, Muller D, Chenard MP, Basset P, Rio MC. 1997. MLN64 exhibits homology with the steroidogenic acute regulatory protein (STAR) and is overexpressed in human breast carcinomas. Int J Cancer 71:183-191.
17. Nemos C, Mansuy V, Vernier-Magnine S, Fraichard A, Jouvenot M, Delage-Mourroux R. 2003. Expression of gec1/GABARAPL1 versus GABARAP mRNAs in human: predominance of gec1/ GABARAPL1 in the central nervous system. Mol Brain Res 119:216-219.
18. Petersen S, Heckert C, Rudolf J, Schlüns K, Tchernitsa OI. Schäfer R, Dietel M, Petersen I. 2000. Gene expression profiling of advanced lung cancer. Int J Cancer 86:512-517.
19. Phillips N, Ziegler M, Saha B, Xynos F. 1993. Allelic loss on chromosome 17 in human ovarian cancer. Int J Cancer 54:85-91.
20. Piao Z, Park C, Park JH, Kim H. 1998. Allelotype analysis of hepatocellular carcinoma. Int J Cancer 75:29-33.
21. Richard F, Pacyna-Gengelbach M, Schlüns K, Fleige B, Winzer KJ, Szymas J, Dietel M, Petersen I, Schwendel A. 2000. Patterns of chromosomal imbalances in invasive breast cancer. Int J Cancer 89:305-310.
22. Seitz S, Poppe K, Fischer J, Nothnagel A, Estévez-Schwarz L, Haensch W, Schlag PM, Scherneck S. 2001. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters. J Pathol 194:318-326.
23. Stack M, Jones D, White G, Liscia DS, Venesio T, Casey G, Crichton D, Varley J, Mitchell E, Heighway J, Santibanez-Koref M. 1995. Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3. Hum Mol Genet 4:2047-2055.
24. Strauss JF III, Liu P. 2002. Sterols and intracellular vesicular trafficking: lessons from the study of NPC1. Steroids 67:947-951.
25. Stronach EA, Sellar GC, Blenkiron C, Rabiasz GJ, Taylor KJ, Miller EP, Massie CE, Al-Nafussi A, Smyth JF, Porteous DJ, Gabra H. 2003. Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression. Cancer Res 63:8648-8655.
26. Tavassoli A, Devilee P. 2003. Pathology and Genetics of Tumors of the Breast and Female Genital Organs. Lyon: IARC. 432 p.
27. Theile M, Hartmann S, Naundorf H, Rueb D, Elbe B, Krause H, Deppert W, Barrett JC, Scherneck S. 1994. Wild-type p53 is not involved in reversion of the tumorigenic phenotype of breast cancer cells after transfer of normal chromosome 17. Int J Oncol 4:1067-1075.
28. Theile M, Hartmann S, Scherthan H, Arnold W, Deppert W, Frege R, Glaab F, Haensch W, Scherneck S. 1995. Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes. Oncogene 10:439-447.
29. Tzachanis D, Freeman GJ, Hirano N, van Puijenbroek AA, Delfs, MW, Berezovskaya A, Nadler LM, Boussoicis VA. 2001. Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat Immunol 2:1174-1182.
30. Varis A, Wolf M, Monni O, Vakkari M-L, Kokkola A, Moskaluk C, Frierson H. Jr., Powell SM, Knuutila S, Kallioniemi A, El-Rifai W. 2002. Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res 62:2625-2629.
31. Wang H, Bedford FK, Brandon NJ, Moss SJ, Olsen RW. 1999. GABA(A)-receptor-associated protein links GABA(A) receptors and the cytoskeleton. Nature 397:69-72.
32. Yoshida Y, Nakamura T, Komoda M, Satoh H, Suzuki T, Tsuzuku JH, Miyasaka T, Yoshida EH, Umemori H, Kunisaki RK, Tani K, Ishii S, Mori S, Suganuma M, Noda T, Yamamoto T. 2003. Mice lacking a transcriptional corepressor Tob are predisposed to cancer. Genes Dev 17:1201-1206.